Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 4962-4969

  Tuttle, Daniel L ^a   Harrison, Jeffrey K ^a   Anders, Cynthia ^a   Sleasman, John W ^a   Goodenow, Maureen M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; VIRUS CELL INTERACTION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 0031901134     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.4962-4969.1998     Document Type: Article

References (54)

1. Aleixo, L. F., M. M. Goodenow, and J. W. Sleasman. 1997. Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus. J. Pediatr. 130:906-914.
2. Aleixo, L. F., M. M. Goodenow, and J. W. Sleasman. 1995. Molecular analysis of highly enriched populations of T-cell-depleted monocytes. Clin. Diagn. Lab. Immunol. 2:733-739.
3. Aleixo, L. F., and M. M. Goodenow. Unpublished data.
4. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
5. Arenzana-Seisdedos, F., J.-L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, B. Moser, and M. Baggiolini. 1996. HIV blocked by chemokine antagonist. Nature 383:400.
6. Bergsma, D., C. Eder, M. Gross, H. Kersten, D. Sylvester, E. Appelbaum, D. Cusimano, G. Livi, M. McLaughlin, K. Kasyan, T. Porter, C. Silverman, D. Dunnington, A. Hand, W. Prichett, M. Bossard, M. Brandt, and M. Levy. 1991. The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms. J. Biol. Chem. 266:23204-23214.
7. Bleul, C. C., R. C. Fuhlbrigge, J. M. Casasnovas, A. Aiuti, and T. A. Springer. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:799-802.
8. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925-1930.
9. Broder, C. C., and R. G. Collman. 1997. Chemokine receptors and HIV. J. Leukocyte Biol. 62:20-29.
10. Chang, J., H. M. Naif, S. Li, J. S. Sullivan, C. M. Randle, and A. L. Cunningham. 1996. Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro. J. Virol. 70:7792-7803.
11. 10a. Cheng-Mayer, C., R. Liu, N. R. Landau, and L. Stamatatos. 1997. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J. Virol. 71:1657-1661.
12. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
13. + T cells. Science 270:1811-1815.
14. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lasso. 1996. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1244-1247.
15. Collota, S., G. Peri, A. Villa, and A. Mantovani. 1984. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. J. Immunol. 132:936.
16. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choc, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621-628.
17. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghof, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saab, C. Rinaldo, R. Detels, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862.
18. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
19. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
20. Dunne, A. L., H. Siregar, J. Mills, and S. Crowe. 1994. HIV replication in chronically infected macrophages is not inhibited by the Tat inhibitors Ro5-3335 and Ro-24-7429. J. Leukocyte Biol. 56:369-373.
21. Hollinger, F. B., J. W. Bremer, L. E. Myers, J. W. Gold, and D. L. McQuay. 1992. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J. Clin. Microbiol. 30:1787-1794.
22. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N. R. Landau, J. Phair, D. D. Ho, and R. A. Koup. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
23. Innocenti-Francillard, P., K. Brengel, C. Guillon, F. Mallet, P. Morand, R. Gruters, and J.-M. Seigneurin. 1994. Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype. AIDS Res. Hum. Retroviruses 10:683-690.
24. Koyanagi, Y., W. A. O'Brien, J. Q. Zhao, D. W. Golde, J. C. Gasson, and I. S. Chen. 1988. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241:1673-1675.
25. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlman, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
26. McElrath, M. J., J. E. Pruett, and Z. A. Cohn. 1989. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. USA 86:675-679.
27. + T lymphocytes in spleens of human immunodeficiency virus-positive patients. J. Virol. 69:4737-4745.
28. Michael, N. L., G. Chang, L. G. Louie, J. R. Mascola, D. Dondero, D. L. Birx, and H. W. Sheppard. 1997. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 3:338-340.
29. + T-cell-derived factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA 93:15341-15345.
30. 28a. Naif, H. M., S. Li, M. Alali, A. Sloane, L. Wu, M. Kelly, G. Lynch, A. Lloyd, and A. L. Cunningham. 1998. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J. Virol. 72:830-836.
31. Nakayama, H., H. Yokoi, and J. Fujita. 1992. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acids Res. 20:4939-4943.
32. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowltz, and D. D. Ho. 1997. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 387:189-191.
33. Reinhardt, P. P., B. Reinhardt, J. L. Lathey, and S. A. Spector. 1995. Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates. J. Clin. Microbiol. 33:292-297.
34. Rich, E. A., I. Chen, J. A. Zack, M. L. Leonard, and W. A. O'Brien. 1992. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89:176-183.
35. Ryffel, B., G. Woerly, B. Greiner, B. Haendler, and M. J. Mihatsch. 1991. Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology 72:399-404.
36. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C.-M. Farber, S. Saragosti, C. Lapoumeroulie, J. Conaux, C. Foceille, G. Muyldermans, C. Verhostede, G. Burtooboy, M. Georges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart, and M. Parmentier. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
37. Schmidtmayerova, H., B. Sherry, and M. Burkinsky. 1996. Chemokines and HIV replication. Nature 382:767.
38. + memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA 87:6058-6062.
39. Schuitemaker, H., N. A. Kootstra, M. Koppelman, M. Bruisten, H. G. Huisman, M. Tersmette, and F. Miedema. 1992. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J. Clin. Invest. 89:1154-1160.
40. Shapiro, H. M. 1995. Cumulative (Overton) subtraction, p. 197. In Practical flow cytometry, 3rd ed. Wiley-Liss, Inc., New York, N.Y.
41. Siebert, P. D. 1993. In Quantitative RT-PCR. Clontech Laboratories, Palo Alto, Calif.
42. Singer-Sam, J., M. O. Robinson, A. R. Bellve, M. I. Simon, and A. D. Riggs. 1990. Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res. 18:1255-1259.
43. Sleasman, J. W., T. O. Harville, G. B. White, J. F. George, D. J. Barrett, and M. M. Goodenow. 1994. Arrested rearrangements of T cell receptor Vβ genes in thymocytes from children with X-linked severe combined immunodeficiency disease. J. Immunol. 153:442-448.
44. + CD45RA inducer T cell subpopulation. Cell. Immunol. 133:367-378.
45. + memory T cells are the predominant population of HIV-1 infected lymphocytes in neonates and children. AIDS 10:1477-1484.
46. Sleasman, J. W., B. H. Leon, L. F. Aleixo, M. Rojas, and M. M. Goodenow. 1997. Immunomagnetic selection of purified monocyte and lymphocyte populations from peripheral blood mononuclear cells following cryopreservation. Clin. Diagn. Lab. Immunol. 4:653-658.
47. Sonza, S., A. Maerz, N. Deacon, J. Meanger, J. Mills, and S. Crowe. 1996. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 70:3863-3869.
48. Sonza, S. A., A. Maerz, S. Uren, A. Violo, S. Hunter, W. Boyle, and S. Crowe. 1995. Susceptibility of human monocytes to HIV type-1 infection in vitro is not dependent on their level of CD4 expression. AIDS Res. Hum. Retroviruses 11:769-776.
49. Spina, C. A., J. C. Guatelli, and D. D. Richman. 1995. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J. Virol. 69:2977-2988.
50. Wong, M., E. D. Silverman, and E. N. Fish. 1997. Evidence for RANTES, MCP-1, and MIP-1β expression in Kawasaki disease. J. Rheumatol. 24:1179-1185.
51. Wu, L., G. LaRosa, N. Kassam, C. J. Gordon, H. Heath, N. Ruffing, H. Chen, J. Humblias, M. Samson, M. Parmentier, J. P. Moore, and C. R. MacKay. 1997. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186:1373-1381.
52. Wu, L., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. MacKay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1 in vitro. J. Exp. Med. 185:1681-1691.
53. Zaitseva, M., A. Blauvelt, S. Lee, C. K. Lapham, V. Klaus-Kovtun, H. Mostowski, J. Manischewitz, and H. Golding. 1997. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 3:1369-1375.
54. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179-1181.